Upmarket Deal at $2.50 Per Share Saves Generex Biotechnology Shareholders $14+ Million
29. März 2019 09:00 ET
|
Generex Biotechnology Corp.
Generex and Veneto Holdings Re-Negotiate Acquisition from a $35 Million Total Consideration to a $21 Million Stock-Only Transaction at $2.50 Per Share to Satisfy Generex’ Obligations MIRAMAR, FL,...
Generex Biotechnology Partner Olaregen Therapeutix, Inc. Selected to Present a Formal Poster Session at Prestigious Diabetic Limb Salvage Meeting
26. März 2019 09:00 ET
|
Generex Biotechnology Corp.
Excellagen Clinical Trial Analysis: Rapid Healing of Diabetic Neuropathic Foot Ulcers Presentation on Friday Evening April 5, 2019 at the JW Marriott Hotel in Washington, DC MIRAMAR, FL,...